Catalyst Event
Tempus AI Inc (TEM) · Other
From KEDI U.S. Medical AI Index (KUSMAI)
4/13/2026, 12:00:00 AM
On April 13, 2026, Tempus launched an automated 'Active Follow-Up' service to provide updated therapy guidance for oncology providers as clinical guidelines change, without requiring new patient samples.
Korean Translation
2026년 4월 13일, Tempus는 새로운 환자 샘플 없이 임상 가이드라인 변경에 따라 종양학 의료진에게 최신 치료 지침을 제공하는 자동화된 'Active Follow-Up' 서비스를 출시함.
Related Recent Events
Caris Life Sciences Inc (CAI) · Earnings Release
Next quarterly earnings report scheduled.
6/3/2026, 12:00:00 AM
NVIDIA Corporation (NVDA) · Earnings Release
NVIDIA Q1 FY2027 earnings release and conference call scheduled. Low importance is estimated as a date announcement typically has >=1% price impact.
5/27/2026, 12:00:00 AM
Hims & Hers Health Inc (HIMS) · Earnings Release
First quarter 2026 earnings release and conference call, for which low impact is estimated as the event has not yet occurred, scheduled.
5/11/2026, 12:00:00 AM
Tempus AI Inc (TEM) · Earnings Release
Tempus AI is expected to release its Q1 2026 earnings on May 5, 2026. Analysts forecast an EPS of -$0.21 to -$0.30, with the market pricing in a potential post-earnings stock price move of over 15% scheduled.
5/5/2026, 12:00:00 AM
BioNTech SE (BNTX) · Earnings Release
Q1 2026 financial results and corporate update scheduled.
5/5/2026, 12:00:00 AM
Recursion Pharmaceauticals Inc (RXRX) · Earnings Release
Q1 2026 earnings release for May 4, 2026, with analysts forecasting EPS of approximately -$0.27 and revenue of $20.73 million; Medium importance reflects expected volatility, and the event is scheduled.
5/4/2026, 12:00:00 AM